COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.

Latest News

Female patient using inhaler | Image Credit: DALU11 - stock.adobe.com
High Rates of Inhaler Misuse Found Among Patients With COPD Using Soft Mist Inhalers

June 12th 2024

Misuse of soft mist inhalers (SMIs) is common among patients with chronic obstructive pulmonary disease (COPD), particularly those with low education levels, higher symptom scores, and a shorter disease duration.

COPD cartoon | Image credit: peterschreiber.media - stock.adobe.com
Dupilumab Improves Pre-, Postbronchodilator Lung Function Measures in Patients With COPD, Type 2 Inflammation

May 23rd 2024

Doctor holding lung animation | Image Credit: mi_viri - stock.adobe.com
Patients With COPD, PRISm at Increased All-Cause, Cause-Specific Mortality Risk

May 20th 2024

Heart animation | Image Credit: Siarhei - stock.adobe.com
Study: Italian Patients With COPD at High Risk of Severe Cardiovascular Events

May 16th 2024

COPD drawing | Image Credit: Ivelin Radkov - stock.adobe.com
Low COPD Diagnosis Rate Among Japanese Patients Indicates Underdiagnosis

May 7th 2024

Continuing Medical Education
June 14th 2024

Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency

1.0 Credit / Pulmonology/Respiratory

More News

Could Platelet Indices Act as an Effective Diagnostic Marker for COPD?
March 16th 2020

Could Platelet Indices Act as an Effective Diagnostic Marker for COPD?

Alison Rodriguez
Platelet indices may be altered in chronic obstructive pulmonary disease and therefore act as a valuable diagnostic marker, according to research.
Lung Volume Reduction Coil Treatment Enables Recovery in Severe COPD Cases
March 11th 2020

Lung Volume Reduction Coil Treatment Enables Recovery in Severe COPD Cases

Matthew Gavidia
In 11 patients with severe cases of COPD and hypercapnic respiratory failure, lung volume reduction coil treatment was associated with significant decreases in carbon dioxide levels and improvement in quality-of-life and respiratory function tests, according to study findings.
Site Logo
March 11th 2020

Evidence-Based Recommendations, Real-World Utilization, and Considerations in the Total Cost of Care in COPD Treatment Strategies

Study Finds 1 Additional Staff Meeting Can Reduce Length of Hospital Stays in Patients With COPD By 67%
February 29th 2020

Study Finds 1 Additional Staff Meeting Can Reduce Length of Hospital Stays in Patients With COPD By 67%

Matthew Gavidia
The implementation of integrated care conferences, a daily meeting for providers to share information, can significantly reduce the length of hospital stays in patients with chronic obstructive pulmonary disease (COPD) by up to 67%, according to study findings.
COPD Closely Linked to Pollution, Outpatient Hospital Visits in Urban Area
February 29th 2020

COPD Closely Linked to Pollution, Outpatient Hospital Visits in Urban Area

Alison Rodriguez
Researchers recently examined 18 diseases represented by outpatient visits to a hospital in Taiwan to determine patterns of the effect of air pollution on different organs and found evidence that concurrent occurrences of diseases show that the immune system tries to create protective defenses.
Statins Significantly Reduce Risk of Hospitalized Exacerbations in Patients With COPD
February 17th 2020

Statins Significantly Reduce Risk of Hospitalized Exacerbations in Patients With COPD

Matthew Gavidia
Statin use was linked with a significant reduction in the risk of hospitalized exacerbations after an initial hospitalized exacerbation among patients with chronic obstructive pulmonary disease (COPD), including specified frequent exacerbators, according to study findings.
Site Logo
February 14th 2020

Care Coordination for Veterans With COPD: A Positive Deviance Study

Ekaterina Anderson, PhD Renda Soylemez Wiener, MD, MPH Kirsten Resnick, MS A. Rani Elwy, PhD Seppo T. Rinne, MD, PhD
Improving relational coordination and reducing structural barriers to collaboration may enhance quality of care for chronic obstructive pulmonary disease (COPD) and other chronic conditions.
In-Home Device Associated With Lower Mortality Risk, Less Need for Intubation in Patients With COPD
February 11th 2020

In-Home Device Associated With Lower Mortality Risk, Less Need for Intubation in Patients With COPD

Matthew Gavidia
In-home noninvasive positive pressure ventilation via bilevel positive airway pressure devices exhibited lower risk of mortality, fewer patients with all-cause hospital admission, and less need for intubation, but had no significant difference in quality-of-life for patients with chronic obstructive pulmonary disease (COPD) and hypercapnia, according to study findings.
Study Describes Genetic Mechanisms Behind Embryonic Lung Cells
February 9th 2020

Study Describes Genetic Mechanisms Behind Embryonic Lung Cells

Alison Rodriguez
The researchers hope the findings could one day lead to cell replacement therapies for respiratory diseases, including chronic obstructive pulmonary disease.
Researchers Assess Impact of Comorbidities, Commonly Used Drugs on Mortality in COPD
February 3rd 2020

Researchers Assess Impact of Comorbidities, Commonly Used Drugs on Mortality in COPD

Matthew Gavidia
Among patients with chronic obstructive pulmonary disease (COPD), heart failure, stroke, and myocardial infarction were highly associated with an increased risk of death. Mortality risk was more strongly associated with the use of long-acting muscarinic antagonists and N-acetylcysteine compared with the lesser risk from inhaled corticosteroids, beta-blockers, and acetylsalicylic acid, according to study findings.
Significant Increase of Arterial Stiffness in Patients With COPD Linked With Severity of Emphysema, Dyslipidemia
February 1st 2020

Significant Increase of Arterial Stiffness in Patients With COPD Linked With Severity of Emphysema, Dyslipidemia

Alison Rodriguez
Although arterial stiffness in patients with chronic obstructive pulmonary disease (COPD) increases over time, a greater annual increase may be associated with the severity of emphysema, systemic inflammation, and dyslipidemia, according to study findings.
Researchers Uncover Differentially Expressed Genes Linked With Development, Progression of COPD
January 28th 2020

Researchers Uncover Differentially Expressed Genes Linked With Development, Progression of COPD

Matthew Gavidia
In study findings demonstrating differentially expressed genes (DEGs) among healthy patients and those with chronic obstructive pulmonary disease (COPD), researchers show that key genes CYP1B1, VEGFA, BCL2, and CDKN1A may have significance in analyzing the development and progression of COPD.
Automated Tool Improves FEV1 Severity Detection in Patients With COPD, Study Shows
January 25th 2020

Automated Tool Improves FEV1 Severity Detection in Patients With COPD, Study Shows

Alison Rodriguez
Extracting lung function measurements from electronic health record (EHR) data through an automated tool, such as Microsoft SQL Server’s full-text search feature, may be efficient and improve the number of values available, leading to improved phenotyping of patients with COPD, according to study findings.
Review Suggests New Strategies of Managing Comorbid COPD, Hypertension
January 23rd 2020

Review Suggests New Strategies of Managing Comorbid COPD, Hypertension

Matthew Gavidia
Researchers discuss optimal approaches to treating hypertension in patients with COPD, with a given patient’s underlying lung function and any coexisting conditions highlighted as important factors of drug therapy choice.
Treating COPD With Combination Therapy
January 16th 2020

Treating COPD With Combination Therapy

Patient-Reported Outcomes in COPD
January 16th 2020

Patient-Reported Outcomes in COPD

Triple Therapy in COPD: IMPACT and FULFIL
January 16th 2020

Triple Therapy in COPD: IMPACT and FULFIL

Triple Therapy for COPD
January 16th 2020

Triple Therapy for COPD

Combination Therapy for COPD
January 16th 2020

Combination Therapy for COPD

Opportunities to Optimize Care in COPD
January 16th 2020

Opportunities to Optimize Care in COPD

Coverage of Combination Regimens for COPD
January 16th 2020

Coverage of Combination Regimens for COPD

COPD Treatment Selection
January 16th 2020

COPD Treatment Selection

Utilization of Treatment Guidelines for COPD
January 16th 2020

Utilization of Treatment Guidelines for COPD

Monitoring Response to Therapy in COPD
January 16th 2020

Monitoring Response to Therapy in COPD

Establishing Goals of Therapy in COPD
January 16th 2020

Establishing Goals of Therapy in COPD

Pulmonary Function Testing in COPD
January 16th 2020

Pulmonary Function Testing in COPD

Accurately Diagnosing COPD
January 16th 2020

Accurately Diagnosing COPD

Progressive Nature of COPD
January 16th 2020

Progressive Nature of COPD

Characteristics That Help Diagnose COPD
January 16th 2020

Characteristics That Help Diagnose COPD

COPD Defined
January 16th 2020

COPD Defined

<1
...
8910111213141516
...
24>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo